Attorney General James Uthmeier Takes Legal Action Against Insulin Manufacturers and Pharmacy Benefit Managers for Pricing Scheme Driving Up Costs for Florida Families

View PDF Release Date Sep 22, 2026 Contact Communications Phone (850) 245-0150 Courtesy of the Office of the Attorney General TALLAHASSEE, Fla. —Attorney General James Uthmeier filed a lawsuit against the three manufacturers that supply more than 90 percent of the world’s insulin—Eli Lilly, Novo Nordisk, and Sanofi—the three pharmacy benefit managers that process roughly 80 percent of U.S. prescriptions—CVS Caremark, Express Scripts, and OptumRx—and rebate aggregators Zinc, Ascent, and Emisar. “These companies told Florida families they were working to make insulin affordable,” said Attorney General James Uthmeier . “Instead, they inflated the sticker price of a medicine people cannot live without and left Florida patients to pay it. My office is holding them accountable.” “Florida families deserve to be treated fairly, especially our most vulnerable residents," said Representative Danny Alvarez . "When companies take advantage of the people who can least afford it, there must be consequences and that’s what this lawsuit will help figure it out. I'm grateful to Attorney General Uthmeier for standing up for Floridians and making sure all wrongdoing is held to account, and they answe

Cancele cuando quiera · 99 CA$/mes